S453-0011 Screening compound: 3-[2-OXO-2-(1,2,3,4-TETRAHYDROQUINOLIN-1-YL)ETHYL]-8-OXA-1,3-DIAZASPIRO[4.5]DECANE-2,4-DIONE

S453-0011 Screening compound: 3-[2-OXO-2-(1,2,3,4-TETRAHYDROQUINOLIN-1-YL)ETHYL]-8-OXA-1,3-DIAZASPIRO[4.5]DECANE-2,4-DIONE
S453-0011 Screening compound: 3-[2-OXO-2-(1,2,3,4-TETRAHYDROQUINOLIN-1-YL)ETHYL]-8-OXA-1,3-DIAZASPIRO[4.5]DECANE-2,4-DIONE alternative view

Chemical Structure Depiction of ChemDiv screening compound S453-0011
3-[2-OXO-2-(1,2,3,4-TETRAHYDROQUINOLIN-1-YL)ETHYL]-8-OXA-1,3-DIAZASPIRO[4.5]DECANE-2,4-DIONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S453-0011

Molecular Formula

C18H21N3O4 (C18 H21 N3 O4)

Compound Name

3-[2-OXO-2-(1,2,3,4-TETRAHYDROQUINOLIN-1-YL)ETHYL]-8-OXA-1,3-DIAZASPIRO[4.5]DECANE-2,4-DIONE

IUPAC name

3-[2-oxo-2-(1234-tetrahydroquinolin-1-yl)ethyl]-8-oxa-13-diazaspiro[4.5]decane-24-dione

SMILES

O=C(CN(C(C1(CCOCC1)N1)=O)C1=O)N(CCC1)c2c1cccc2

InChI

InChI=1S/C18H21N3O4/c22-15(20-9-3-5-13-4-1-2-6-14(13)20)12-21-16(23)18(19-17(21)24)7-10-25-11-8-18/h1-2,4,6H,3,5,7-12H2,(H,19,24)

InChI Key

QNIBPAAACITUTK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29011608

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

343.38

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.058

Distribution Coefficient, logD

1.058

Water Solubility, LogSw

-2.15

Polar Surface Area

64.803

Acid Dissociation Constant (pKa)

11.79

Base Dissociation Constant (pKb)

1.91

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

S453-0011 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

SH2 Library (10483 compounds)

Soluble Diversity Library (15920 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S453-0011 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S453-0011?
Check Price and Availability of S453-0011, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S453-0011 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S453-0011
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S453-0011
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S453-0011 available by request